Open AccessSecretory prostate apoptosis response (Par)‐4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen‐induced cell death
Author(s) -
Jagtap Jayashree C.,
Parveen D.,
Shah Reecha D.,
Desai Aarti,
Bhosale Dipali,
Chugh Ashish,
Ranade Deepak,
Karnik Swapnil,
Khedkar Bhushan,
Mathur Aaishwarya,
Natesh Kumar,
Chandrika Goparaju,
Shastry Padma
Publication year - 2015
Publication title -
febs open bio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.718
H-Index - 31
ISSN - 2211-5463
DOI - 10.1016/j.fob.2014.11.005
Subject(s) - apoptosis , cancer research , programmed cell death , cytotoxicity , cell culture , glioma , cell , prostate cancer , cytotoxic t cell , biology , cancer , medicine , in vitro , biochemistry , genetics
Glioblastoma multiforme (GBM) is the most malignant form of brain tumor and is associated with resistance to conventional therapy and poor patient survival. Prostate apoptosis response (Par)‐4, a tumor suppressor, is expressed as both an intracellular and secretory/extracellular protein. Though secretory Par‐4 induces apoptosis in cancer cells, its potential in drug‐resistant tumors remains to be fully explored. Multicellular spheroids (MCS) of cancer cells often acquire multi‐drug resistance and serve as ideal experimental models. We investigated the role of Par‐4 in Tamoxifen (TAM)‐induced cell death in MCS of human cell lines and primary cultures of GBM tumors. TCGA and REMBRANT data analysis revealed that low levels of Par‐4 correlated with low survival period (21.85 ± 19.30 days) in GBM but not in astrocytomas (59.13 ± 47.26 days) and oligodendrogliomas (58.04 ± 59.80 days) suggesting low PAWR expression as a predictive risk factor in GBM. Consistently, MCS of human cell lines and primary cultures displayed low Par‐4 expression, high level of chemo‐resistance genes and were resistant to TAM‐induced cytotoxicity. In monolayer cells, TAM‐induced cytotoxicity was associated with enhanced expression of Par‐4 and was alleviated by silencing of Par‐4 using specific siRNA. TAM effectively induced secretory Par‐4 in conditioned medium (CM) of cells cultured as monolayer but not in MCS. Moreover, MCS were rendered sensitive to TAM‐induced cell death by exposure to conditioned medium (CM)‐containing Par‐4 (derived from TAM‐treated monolayer cells). Also TAM reduced the expression of Akt and PKCζ in GBM cells cultured as monolayer but not in MCS. Importantly, combination of TAM with inhibitors to PI3K inhibitor (LY294002) or PKCζ resulted in secretion of Par‐4 and cell death in MCS. Since membrane GRP78 is overexpressed in most cancer cells but not normal cells, and secretory Par‐4 induces apoptosis by binding to membrane GRP78, secretory Par‐4 is an attractive candidate for potentially overcoming therapy‐resistance not only in malignant glioma but in broad spectrum of cancers.